The Global Citizen Hub Announces Launch of European Scholarship Database for International Students
Austin, Texas, Sept. 17, 2025 (GLOBE NEWSWIRE) -- The Global Citizen Hub…
C3.AI SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against C3.ai, Inc. – AI
NEW ORLEANS, Sept. 17, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder…
DOW SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Dow Inc. – DOW
NEW ORLEANS, Sept. 17, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder…
Arcutis To Present Multiple New ZORYVE (roflumilast) Data Analyses at European Academy of Dermatology and Venereology Congress
New analysis of ZORYVE foam 0.3% demonstrates reduction in signs and symptoms…
ALK and GenSci partner to expand the AIT market in China
Inside Information GenSci is granted exclusive rights to ALK’s house dust mite…
Opterion Health AG submits Clinical Trial Application for First-in-Human Study of OPT101 in Patients with Advanced Chronic Kidney Disease
MUTTENZ, Switzerland, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Opterion Health AG, a…
Telnyx Expands to Sydney with New Office Location, Bringing Real-Time AI Voice Infrastructure to APAC
SYDNEY, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Telnyx, the full-stack conversational AI…
Geotabs New AI Dash Cam Slashes Risky Driving Behaviors by Up to 95% with In Cab Verbal Alerts
Latest video intelligence solution transforms fleet safety by empowering drivers with instant…
Intermap Technologies Files Final Short-Form Base Shelf Prospectus
Final Short-Form Base Shelf Prospectus Is accessible on SEDAR+ and EDGAR September…
Pasithea Therapeutics Announces Activation of Clinical Trial Sites in South Korea for Phase 1/1b Trial of PAS-004 in Adult NF1 Patients
MIAMI, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA)…
